Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century
Cancers · 16.05.2023 · 15 (10) · 2782
DOI: 10.3390/cancers15102782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 16.05.2023. Verfasst von Filip Tichanek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 30605 Pilsen, Czech Republic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the European Union's Horizon 2020 research and innovation programme, The Swedish Research Council, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Finnish Cancer Organizations, University of Helsinki, Helsinki Unive…, European Union’s Horizon 2020 research and innovation programme.
Abstract (Originalsprache)
Kidney and bladder cancers share etiology and relatively good recent survival, but long-term studies are rare. We analyzed survival for these cancers in Denmark, Finland, Norway (NO), and Sweden (SE) over a 50-year period (1971–2020). Relative 1- and 5-year survival data were obtained from the NORDCAN database, and we additionally calculated conditional 5/1-year survival. In 2016–2020, 5-year survivals for male kidney (79.0%) and bladder (81.6%) cancers were best in SE. For female kidney cancer, NO survival reached 80.0%, and for bladder cancer, SE survival reached 76.1%. The magnitude of 5-year survival improvements during the 50-year period in kidney cancer was over 40% units; for bladder cancer, the improvement was over 20% units. Survival in bladder cancer was worse for women than for men, particularly in year 1. In both cancers, deaths in the first year were approximately as many as in the subsequent 4 years. We could document an impressive development for kidney cancer with tripled male and doubled female 5-year survival in 50 years. Additionally, for bladder cancer, a steady improvement was recorded. The current challenges are to curb early mortality and target treatment to reduce long-term mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 30605 Pilsen, Czech Republic.
- Institute of Pathological Physiology, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic.
- Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
- Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
- Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, 00290 Helsinki, Finland.
- Comprehensive Cancer Center, Helsinki University Hospital, 00290 Helsinki, Finland.
ORCID-Profile: Asta Försti, Akseli Hemminki, Kari Hemminki
Förderung
- the European Union's Horizon 2020 research and innovation programme
- The Swedish Research Council, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Finnish Cancer Organizations, University of Helsinki, Helsinki Unive…
- European Union’s Horizon 2020 research and innovation programme
- Swedish Research Council, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Finnish Cancer Organizations, University of Helsinki, Helsinki Universit…
Zitieren
APA
Tichanek, F., Försti, A., Hemminki, A., Hemminki, O., & Hemminki, K. (2023). Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century. Cancers, 15(10), 2782. https://doi.org/10.3390/cancers15102782
Vancouver
Tichanek F, Försti A, Hemminki A, Hemminki O, Hemminki K. Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century. Cancers. 2023;15(10):2782. doi:10.3390/cancers15102782
BibTeX
@article{Tichanek2023,
author = {Tichanek, Filip and Försti, Asta and Hemminki, Akseli and Hemminki, Otto and Hemminki, Kari},
title = {Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century},
journal = {Cancers},
year = {2023},
volume = {15},
number = {10},
pages = {2782},
doi = {10.3390/cancers15102782}
}
EUVIMED